Distillate Capital Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9M Buy
+103,554
New +$28.6M 1.19% 20
2025
Q1
Sell
-89,666
Closed -$20.8M 123
2024
Q4
$20.8M Sell
89,666
-8,261
-8% -$1.9M 1.02% 28
2024
Q3
$21.6M Sell
97,927
-1,113
-1% -$230K 1.08% 36
2024
Q2
$19.5M Buy
+99,040
New +$20.5M 1.03% 27
2021
Q3
Sell
-14,676
Closed -$3.12M 115
2021
Q2
$3.12M Buy
14,676
+818
+6% +$173K 0.87% 45
2021
Q1
$2.83M Buy
13,858
+3,640
+36% +$717K 0.92% 36
2020
Q4
$1.82M Buy
+10,218
New +$1.74M 0.87% 47

Other funds holding CME

Distillate Capital Partners's CME Position: Q2 2026 in Review

Distillate Capital Partners opened a new position in CME Group (CME) in Q2 2026: 103,554 shares worth $22.9M. The stake represents 1.19% of the portfolio and ranks #20 among its holdings. This is a return to the name: Distillate Capital Partners previously reported a position in CME as recently as Q4 2024.

Distillate Capital Partners first reported a position in CME in Q4 2020 and has held it in 7 quarters since. 1,707 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Distillate Capital Partners held 103,554 shares of CME Group worth $22.9M as of Q2 2026.
  • CME Group was a new Distillate Capital Partners position in Q2 2026.
  • CME Group made up 1.19% of Distillate Capital Partners's portfolio in Q2 2026, its #20 holding.
  • Distillate Capital Partners first reported a position in CME Group in Q4 2020 and has held it in 7 quarters since.
  • 1,707 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Distillate Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.